查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1709486

患者参与解决方案市场，按组件、按治疗领域、按交付模式、按应用、按国家和地区 - 2025 年至 2032 年全球行业分析、市场规模、市场份额和预测

Patient Engagement Solutions Market, By Component, By Therapeutic Area, By Delivery Mode, By Application, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 269 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告重点

2024 年病患参与解决方案市场规模价值 276.5043 亿美元，2025 年至 2032 年的复合年增长率为 21.10%。

患者参与解决方案市场-市场动态

远距医疗的普及和数位化整合正在改变患者参与解决方案

远距医疗的采用和数位化整合日益普及，正在改变患者参与解决方案，美国医学会 (AMA) 报告称，目前超过 60% 的美国医疗保健提供者使用虚拟护理平台。世界卫生组织 (WHO) 强调了数位健康在提高患者依从性方面的作用，因为行动健康应用程式已显示慢性病管理成功率提高了 40%。美国《经济与临床健康资讯科技法案》（HITECH）等政府措施正在推广安全的电子健康记录（EHR）和符合 HIPAA 标准的患者门户，以提高可访问性。同时，人工智慧聊天机器人和穿戴式健康设备正在重塑即时病患监测，利用预测分析减少医院再入院率。随着基于云端的平台简化医疗保健工作流程，产业参与者正在投资人工智慧驱动的解决方案，以进一步增强参与度，确保数位转型继续在全球重塑以患者为中心的医疗服务。

病患参与解决方案市场—关键见解

根据我们的研究分析师的分析，预计全球市场在预测期内（2025-2032 年）的年复合成长率约为 21.10%。

根据组件细分，预计软体将在 2024 年占据最大市场份额

根据治疗领域细分，慢性病是 2024 年领先的治疗领域

根据交付模式细分，云端交付模式是 2024 年领先的交付模式

按地区划分，北美是 2024 年的主要收入来源

患者参与解决方案市场-細項分析：

全球患者参与解决方案市场根据组件、治疗领域、交付模式、应用和地区进行细分。

根据组件，市场分为三类：软体、服务和硬体。由于 EHR 平台、患者入口网站和 AI 驱动的参与工具的日益普及，软体引领了市场。随着实施、培训和支援需求的不断增长，服务也随之而来。硬体占比较小，主要包括自助服务终端和穿戴式健康设备。

根据治疗领域，市场分为两类：慢性病、健身、女性健康和心理健康。随着患者参与解决方案增强了对糖尿病和心血管疾病等疾病的管理，慢性病占据了市场主导地位。心理健康紧随其后，受到远距治疗采用率不断提高的推动。受益于行动健康应用程式和穿戴式设备，女性健康和健身占据较小的份额。

患者参与解决方案市场-地理洞察

患者参与解决方案市场正在全球扩张，其中北美由于其强大的医疗保健基础设施、较高的远距医疗采用率以及《HITECH 法案》等政府倡议推动数位医疗解决方案而处于领先地位。美国医疗保险和医疗补助服务中心 (CMS) 已经推出了激励患者参与工具，推动了 EHR 的广泛整合。欧洲紧随其后，在通用资料保护规范（GDPR）等监管政策的支持下，确保安全的数位病患互动。亚太地区正在经历快速成长，中国、日本和印度等国家正在增加对远距医疗和行动医疗应用的投资，以提高医疗保健的可近性。在拉丁美洲，网路普及率的提高和政府主导的数位健康计画正在促进市场成长，而中东和非洲则透过智慧医疗计画和与全球科技公司的合作逐步采用病患参与平台。随着数位医疗的普及，基础设施和监管方面的地区差异继续影响着市场扩张。

病患参与解决方案市场-竞争格局：

患者参与解决方案市场竞争激烈，主要参与者专注于人工智慧驱动的平台、远距医疗整合和安全资料管理，以增强患者互动。 Epic Systems、Cerner（Oracle Health）和 Allscripts 等领先公司透过广泛的 EHR 整合和基于云端的解决方案主导市场。飞利浦、美敦力和通用电气医疗集团正在投资穿戴式健康技术和用于远端患者监控的人工智慧分析。 MyChart 和 Welltok 等新兴企业透过提供针对个人化医疗客製化的行动参与工具获得了关注。策略合作，例如微软与 Nuance 在人工智慧驱动的临床文件方面的合作，正在进一步重塑该产业。法规遵从性，特别是 HIPAA、GDPR 和 HL7 标准，仍然是一个重点，确保安全处理病患资料。随着对虚拟护理的需求不断增加，公司优先考虑可扩展性、互通性和即时患者参与度，加剧了这个快速发展的市场的竞争。

最新动态：

2025 年 2 月，Smart Meter 在 HIMSS 2025 上推出了 SmartHealth Solutions，这是一套旨在提高患者参与度的人工智慧工具。这些解决方案包括慢性病管理应用程式、RTM 步态分析、AI 增强血压指导、心房颤动监测以及用于患者与提供者互动的 AI 化身，所有这些都旨在改善健康结果。

2024 年 9 月，PatientPoint 推出了 PatientPoint Focus(TM)（现为 Precision(TM)），这是一种可在就诊前、就诊后和就诊期间实现 1:1 患者互动的解决方案。使用可信的沟通管道和同意的 EHR资料，它向患者提供相关的教育内容，使他们能够与医生进行更有效的对话，并为他们的健康采取更好的行动。

目录

第 1 章：患者参与解决方案市场概述

  • 研究范围
  • 市场估计年限

第二章：执行摘要

  • 市场片段
    • 患者参与解决方案市场片段（按组件）
    • 患者参与解决方案市场片段（按治疗领域）
    • 患者参与解决方案市场片段（按交付模式）
    • 患者参与解决方案市场片段（按应用）
    • 患者参与解决方案市场片段（按国家/地区）
    • 患者参与解决方案市场片段（按地区）
  • 竞争洞察

第三章：患者参与解决方案关键市场趋势

  • 患者参与解决方案市场驱动因素
    • 市场驱动因素的影响分析
  • 患者参与解决方案市场限制
    • 市场限制的影响分析
  • 患者参与解决方案市场机会
  • 患者参与解决方案市场未来趋势

第四章：病患参与解决方案产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第五章：病患参与解决方案市场：地缘政治紧张局势升级的影响

  • COVID-19 疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：病患参与解决方案市场格局

  • 2024 年病患参与解决方案市占率分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第七章：病患参与解决方案市场 - 按组件

  • 概述
    • 按组件分類的细分市场占有率分析
    • 软体
    • 服务
    • 硬体

第 8 章：病人参与解决方案市场 - 按治疗领域

  • 概述
    • 按治疗领域分類的细分市场占有率分析
    • 慢性疾病
    • 健康
    • 女性健康
    • 心理健康
    • 其他的

第九章：患者参与解决方案市场－按交付模式

  • 概述
    • 按交付方式分類的细分市场份额分析
    • 本地部署
    • 基于云端

第 10 章：患者参与解决方案市场 - 按应用

  • 概述
    • 按应用细分市场占有率分析
    • 健康管理
    • 家庭健康管理
    • 社会与行为管理
    • 财务健康管理

第 11 章：病患参与解决方案市场 - 按地理划分

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美患者参与解决方案主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模及预测（按组件划分）
    • 北美市场规模及预测（按治疗领域）
    • 北美市场规模及预测（以交付方式）
    • 北美市场规模和预测（按应用）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲患者参与解决方案主要製造商
    • 欧洲市场规模及预测（按国家/地区）
    • 欧洲市场规模及预测（按组成部分）
    • 欧洲市场规模及预测（按治疗领域）
    • 欧洲市场规模及预测（以交付方式）
    • 欧洲市场规模和预测，按应用
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区患者参与解决方案主要製造商
    • 亚太地区市场规模及预测（依国家）
    • 亚太地区市场规模及预测（按组成部分）
    • 亚太地区市场规模及预测（依治疗领域）
    • 亚太地区市场规模及预测（以交付方式）
    • 亚太地区市场规模及预测（按应用）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲患者参与解决方案主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（按组成部分）
    • 拉丁美洲市场规模及预测（按治疗领域）
    • 拉丁美洲市场规模及预测（以交付方式）
    • 拉丁美洲市场规模及预测（按应用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲（MEA）
    • 概述
    • 中东和非洲患者参与解决方案主要製造商
    • MEA 市场规模及预测（依国家/地区）
    • MEA 市场规模及预测（按组件）
    • MEA 市场规模及预测（依治疗领域）
    • MEA 市场规模及预测（以交付方式）
    • MEA 市场规模及预测（按应用）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其余地区

第 12 章：关键供应商分析-病患参与解决方案产业

  • 竞争仪錶板
    • Competitive Benchmarking
    • Competitive Positioning
  • 公司简介
    • Allscripts Healthcare Solutions, Inc.
    • Athenahealth, Inc.
    • Cerner Corporation
    • CureMD Healthcare
    • eClinicalWorks
    • Epic Systems Corporation
    • Get Real Health
    • GetWellNetwork, Inc.
    • IBM Corporation
    • Lincor Solutions Ltd.
    • McKesson Corporation
    • Medecision, Inc.
    • Oneview Healthcare PLC
    • Orion Health Ltd.
    • WelVU
    • YourCareUniverse, Inc.
    • Others

第 13 章：360 度分析师视角

第 14 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4959

REPORT HIGHLIGHT

Patient Engagement Solutions Market size was valued at US$ 27,650.43 Million in 2024, expanding at a CAGR of 21.10% from 2025 to 2032.

The Patient Engagement Solutions Market focuses on digital tools and platforms that enhance patient-provider interactions, improve healthcare outcomes, and streamline communication. Increasing adoption of telehealth, with over 40% of U.S. adults using virtual care services, has accelerated demand for these solutions. Government initiatives, such as the CMS Interoperability and Patient Access Rule, are pushing healthcare providers toward integrated engagement platforms. However, data security concerns and interoperability challenges hinder seamless implementation. High initial investment costs also pose barriers for smaller healthcare facilities. Despite these challenges, advancements in AI-driven chatbots and mobile health apps, along with the integration of wearable devices-used by over 30% of global consumers for health monitoring-are creating significant market opportunities. Strategic collaborations between tech companies and healthcare providers are further driving innovation, making patient-centric healthcare more accessible and efficient.

Patient Engagement Solutions Market- Market Dynamics

Rising telehealth adoption and digital integration, transforming patient engagement solutions

Rising telehealth adoption and digital integration are transforming patient engagement solutions, with the American Medical Association (AMA) reporting that over 60% of U.S. healthcare providers now use virtual care platforms. The World Health Organization (WHO) has emphasized digital health's role in improving patient adherence, as mobile health apps have shown a 40% increase in chronic disease management success. Government initiatives, such as the U.S. Health IT for Economic and Clinical Health (HITECH) Act, is promoting secure electronic health records (EHRs) and HIPAA-compliant patient portals to enhance accessibility. Meanwhile, AI-powered chatbots and wearable health devices are reshaping real-time patient monitoring, reducing hospital readmissions by leveraging predictive analytics. As cloud-based platforms streamline healthcare workflows, industry players are investing in AI-driven solutions to further enhance engagement, ensuring that digital transformation continues to reshape patient-centered care globally.

Patient Engagement Solutions Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 21.10% over the forecast period (2025-2032)

Based on Component segmentation, Software was predicted to show maximum market share in the year 2024

Based on Therapeutic Area segmentation, Chronic Diseases was the leading Therapeutic Area in 2024

Based on Delivery Mode segmentation, Cloud-Based was the leading Delivery Mode in 2024

On the basis of region, North America was the leading revenue generator in 2024

Patient Engagement Solutions Market- Segmentation Analysis:

The Global Patient Engagement Solutions Market is segmented on the basis of Component, Therapeutic Area, Delivery Mode, Application, and Region.

The market is divided into three categories based on Component: Software, Services, and Hardware. Software leads the market due to the rising adoption of EHR platforms, patient portals, and AI-driven engagement tools. Services follow, driven by increasing demand for implementation, training, and support. Hardware holds a smaller share, mainly comprising kiosks and wearable health devices.

The market is divided into two categories based on Therapeutic Area: Chronic Diseases, Fitness, Women's Health, and Mental Health. Chronic Diseases dominate the market as patient engagement solutions enhance management of conditions like diabetes and cardiovascular diseases. Mental Health follows, driven by increasing teletherapy adoption. Women's Health and Fitness hold smaller shares, benefiting from mobile health apps and wearable devices.

Patient Engagement Solutions Market- Geographical Insights

The Patient Engagement Solutions Market is expanding globally, with North America leading due to strong healthcare infrastructure, high telehealth adoption, and government initiatives like the HITECH Act promoting digital health solutions. The U.S. Centers for Medicare & Medicaid Services (CMS) has incentivized patient engagement tools, driving widespread EHR integration. Europe follows closely, supported by regulatory policies such as the General Data Protection Regulation (GDPR), ensuring secure digital patient interactions. The Asia-Pacific region is experiencing rapid growth, with countries like China, Japan, and India increasing investments in telemedicine and mobile health applications to enhance healthcare accessibility. In Latin America, expanding internet penetration and government-led digital health initiatives are fostering market growth, while the Middle East & Africa are gradually adopting patient engagement platforms through smart healthcare projects and collaborations with global tech firms. As digital health adoption rises, regional disparities in infrastructure and regulations continue to shape market expansion.

Patient Engagement Solutions Market- Competitive Landscape:

The Patient Engagement Solutions Market is highly competitive, with key players focusing on AI-driven platforms, telehealth integration, and secure data management to enhance patient interactions. Leading companies like Epic Systems, Cerner (Oracle Health), and Allscripts dominate the market through extensive EHR integration and cloud-based solutions. Philips, Medtronic, and GE Healthcare are investing in wearable health technologies and AI-powered analytics for remote patient monitoring. Emerging players, such as MyChart and Welltok, are gaining traction by offering mobile-based engagement tools tailored for personalized healthcare. Strategic collaborations, such as Microsoft's partnership with Nuance for AI-driven clinical documentation, are further reshaping the industry. Regulatory compliance, particularly HIPAA, GDPR, and HL7 standards, remains a key focus, ensuring secure patient data handling. With increasing demand for virtual care, companies are prioritizing scalability, interoperability, and real-time patient engagement, intensifying competition in this rapidly evolving market.

Recent Developments:

In February 2025, Smart Meter unveils SmartHealth Solutions at HIMSS 2025, a suite of AI-powered tools designed to elevate patient engagement. The solutions include a chronic care management app, gait analysis for RTM, AI-enhanced blood pressure coaching, Afib monitoring, and an AI avatar for patient-provider interactions, all aimed at improving health outcomes.

In September 2024, PatientPoint launched PatientPoint Focus(TM) (now Precision(TM)), a solution enabling 1:1 patient engagement before, after, and between visits. Using trusted communication channels and consented EHR data, it delivers relevant educational content to patients, empowering them to have more effective conversations with their doctors and take better actions toward their health.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Allscripts Healthcare Solutions, Inc.
  • Athenahealth, Inc.
  • Cerner Corporation
  • CureMD Healthcare
  • eClinicalWorks
  • Epic Systems Corporation
  • Get Real Health
  • GetWellNetwork, Inc.
  • IBM Corporation
  • Lincor Solutions Ltd.
  • McKesson Corporation
  • Medecision, Inc.
  • Oneview Healthcare PLC
  • Orion Health Ltd.
  • WelVU
  • YourCareUniverse, Inc.
  • Others

GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032

  • Software
  • Services
  • Hardware

GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY THERAPEUTIC AREA- MARKET ANALYSIS, 2019 - 2032

  • Chronic Diseases
  • Fitness
  • Women's Health
  • Mental Health
  • Others

GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DELIVERY MODE- MARKET ANALYSIS, 2019 - 2032

  • On-Premise
  • Cloud-Based

GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Health Management
  • Home Health Management
  • Social and Behavioral Management
  • Financial Health Management

GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Patient Engagement Solutions Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Patient Engagement Solutions Market Snippet by Component
    • 2.1.2. Patient Engagement Solutions Market Snippet by Therapeutic Area
    • 2.1.3. Patient Engagement Solutions Market Snippet by Delivery Mode
    • 2.1.4. Patient Engagement Solutions Market Snippet by Application
    • 2.1.5. Patient Engagement Solutions Market Snippet by Country
    • 2.1.6. Patient Engagement Solutions Market Snippet by Region
  • 2.2. Competitive Insights

3. Patient Engagement Solutions Key Market Trends

  • 3.1. Patient Engagement Solutions Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Patient Engagement Solutions Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Patient Engagement Solutions Market Opportunities
  • 3.4. Patient Engagement Solutions Market Future Trends

4. Patient Engagement Solutions Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Patient Engagement Solutions Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Patient Engagement Solutions Market Landscape

  • 6.1. Patient Engagement Solutions Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Patient Engagement Solutions Market - By Component

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Component, 2024 & 2032 (%)
    • 7.1.2. Software
    • 7.1.3. Services
    • 7.1.4. Hardware

8. Patient Engagement Solutions Market - By Therapeutic Area

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Therapeutic Area, 2024 & 2032 (%)
    • 8.1.2. Chronic Diseases
    • 8.1.3. Fitness
    • 8.1.4. Women's Health
    • 8.1.5. Mental Health
    • 8.1.6. Others

9. Patient Engagement Solutions Market - By Delivery Mode

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Delivery Mode, 2024 & 2032 (%)
    • 9.1.2. On-Premise
    • 9.1.3. Cloud-Based

10. Patient Engagement Solutions Market - By Application

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 10.1.2. Health Management
    • 10.1.3. Home Health Management
    • 10.1.4. Social and Behavioral Management
    • 10.1.5. Financial Health Management

11. Patient Engagement Solutions Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Patient Engagement Solutions Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Patient Engagement Solutions Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Patient Engagement Solutions Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Patient Engagement Solutions Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Patient Engagement Solutions Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Delivery Mode, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Patient Engagement Solutions Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Allscripts Healthcare Solutions, Inc.
    • 12.2.2. Athenahealth, Inc.
    • 12.2.3. Cerner Corporation
    • 12.2.4. CureMD Healthcare
    • 12.2.5. eClinicalWorks
    • 12.2.6. Epic Systems Corporation
    • 12.2.7. Get Real Health
    • 12.2.8. GetWellNetwork, Inc.
    • 12.2.9. IBM Corporation
    • 12.2.10. Lincor Solutions Ltd.
    • 12.2.11. McKesson Corporation
    • 12.2.12. Medecision, Inc.
    • 12.2.13. Oneview Healthcare PLC
    • 12.2.14. Orion Health Ltd.
    • 12.2.15. WelVU
    • 12.2.16. YourCareUniverse, Inc.
    • 12.2.17. Others

13. 360 Degree AnalystView

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us